Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Amazing you went through that whole discussion only to in the end admit the poster was right that UCLA is not using DCVax. I think everybody knows that NWBO owns the DCVax name. The question is why isn't UCLA using it?
We are now five months since they announced data lock, and we haven't heard a word since. Every single person in the world knows for a fact that if they had something good to report they wouldn't have sat on it for five months. Everybody knows that. All of your and Dr. Bala's supposedly thorough research and due diligence would be a lot more valuable if you guys would start asking some legitimate questions about what is really going on here instead of playing company propagandists every time. If shareholders would finally stand up to the liars running this company maybe we wouldn't be jerked around like this.
Eventually, everyone on this message board comes around to what I've been saying now for years. This trial has been a waste of everyone's time since 2015, which is when they first learned it failed, and instead of stopping and starting over, they decided to plow ahead with a mess of a situation on their hands that they knew would involve changing then endpoints, among other things. That's when the trial became a complete joke - beyond even a longshot. This whole situation has been so mismanaged by completely incompetent and unethical people. They are a disgrace.
Won't be long before everyone here comes understand that everything else I've been telling you is true, too.
All of this would be so much more convincing if we hadn't done this exact same drill oh, I don't know, a few dozen times before.
That's because NWBO is a scam. They've been screwing common shareholders for a long, long time and are still doing it at this very moment. And no one seems to care . . .
So what's your explanation?
How about this: they were planning to buy back 400 million shares at $.14 and now that's all out the window. Ha ha! LOL! Just kidding!
I mean, the most obvious explanation is they are trying to dump this pos and the recent share price escalation completely destroyed the valuation. They can't very well sell the company for $.14 when it is trading at ten times that now can they? Whatever the explanation is, you can be assured it has nothing to do with making common shareholders better off. That's the only guarantee you can 100 percent count on.
Funny how the die-hards here don't like to talk about what she did with Cognate. Even the hardest of the hard-core know how bad that one was as they write their little "CEO of the Decade!" and Nobel Prize posts. I'm sure she's got something similar cooked up for this round. There's a great old film called "Three Days of the Condor" and one of my favorite lines is when Turner says to Higgins, "Boy, what is it with you people? You think not getting caught in a lie is the same thing as telling the truth!" Except the people running NWBO are way past the point of even caring whether they get caught in their web of lies. Nothing about what they are doing makes any sense at all, and that's when you know the scene at headquarters must be chaos. Like the bridge of the Titanic after it hit that iceberg, or a boiler room right before the raid.
Does the way DI responds to shareholders in any way reflect the persona of someone sitting on a gold mine of good news? No, it reflects the persona of someone who already has his back up in a defensive posture. I wonder why that would be?
There are a lot of flags waving right now, and they are all dripping with red ink.
You people really did some great due diligence on DCVax. I mean that. I have learned a lot from you people about this important vaccine treatment. Unfortunately, all of us completely dropped the ball when it came to doing due diligence on the people running NWBO. That will be our downfall.
Amazing to watch UCLA take off with a Dendritic cell study of their own that has nothing to do with NWBO. People here keep acting like it does, but the UCLA study is completely divorced from NWBO. The people who claim otherwise are lying. In fact, while UCLA is using a vaccine that is similar to DCVax, they went out of their way to not call it by the name that NWBO gave it. No, for some reason UCLA is calling it a Dendritic Cell Tumor Cell Lysate Vaccine. What's remarkable is that the official trial record on clinicaltrials.gov requires them to list all alternative names for the drug. For instance, the study is also using Pembrolizumab, and for an alternative name it lists "Keytruda." So, naturally, you would think that a list of alternate names for Dendritic Cell Tumor Cell Lysate Vaccine would at the very least include "DCVax-L". But no, there is no listing of DCVax-L to be found. That's because UCLA has moved on from NWBO. They don't need them anymore, and are tired of waiting around while the company plays games while people's lives are on the line. If you don't believe me you can see for yourself if you click here.
And now we see a huge deal to purchase Cognate, a company that moved on from NWBO a long time ago - after almost suing them, LOL. Still collects a monthly fee from them for doing nothing, but just like UCLA, Cognate doesn't need NWBO in the least. In fact, from their most recent press release before this one, they have totally expanded their operations and have multiple new vaccines lined up for production, none of which include DCVax.
As NWBO fiddles, the world moves on. Meanwhile, we put our trust in a bunch of liars. That was our mistake.
Ha, ha! LOL! SOC, really? It's on its way to being memory-holed. The company in charge of this fiasco trial is refusing to release the data, which is what they've been doing for the last six years. They are hoping we'll all just go away and forget about it. Nice try, though!
I think your analysis needs a bit more detail. To be fair to the newbie, you should have clarified that the share price is what it is because of:
- Company missteps and general disdain toward common shareholders: 90 percent
- Shorts: 6 percent
- FUDS: 4 percent
Otherwise he might get the mistaken impression that the share price isn't merited.
The apologizing and excuse-making continues full bore! Now we have shareholders threatening the IR guy's family. Are you serious? Where did you get that? This kind of BS is so irresponsible when there is no evidence whatsoever to support such an outrageous claim. In fact, it's beyond irresponsible. There is no excuse - NONE! - for the way this person, whose job is to interact with shareholders in a courteous manner and to put out press releases that contain facts and not lies, actually treats the people who have spent their hard-earned money to buy shares of this crap company. If he worked for me I would have fired his ass long ago, but here we find this post, as usual, making up ridiculous claims out of thin air to apologize for his inexcusable behavior.
How long have you been here? All of us, every single one, will eventually learn who these people really are and what they are really doing. It took me several years to figure it out. There are others who have been here longer than I who still think everything is hunky dory and just "stay tuned". Except for the ones intentionally misleading us with gross apologies and excuses for everything this company does or does not do (and there are several), those people are going to learn the hard way when the rug gets pulled. So kudos to you for at least figuring it out on your own before it's too late. The Investor Relations person's behavior and tone are not characteristic of someone sitting on a gold mine of good news for investors. That ought to tell you all you need to know.
All this company does is disappoint in everything they do. That has been true for 10 or more years and isn't going to change now.
Caution to those who do not understand the difference between a promising vaccine and what it takes to get such a vaccine approved and into the hands of doctors. I hate to break this to you, but interim trial numbers that are blinded and blended don't mean a thing.
A promising vaccine requires a talented and creative inventor. Getting it approved requires a highly competent and effective biotech company.
NWBO may have the former, but clearly it does not have the latter. Why is that so hard for some to understand? The incompetence of this management team torpedoed a once-promising product. They should have scrapped the trial and started over five years ago. Now we're stuck watching a company that locked data four months ago trying to figure out what they're going to do now.
The people (like Joan Lappin) posting that this is some kind of NWBO-Merck joint venture are out of their effing minds. NWBO has nothing to do with what is going on at UCLA right now. Nothing! The people who try to claim otherwise are just lying. NWBO the company is not mentioned in anything that Linda Liau is doing, and there is a reason for that. She has washed her hand of NWBO.
This insanity has to stop. People are just spreading lies to pump this stock when anyone with eyes can see there is nothing going on and NWBO is more than four months past data lock and is refusing to release the data.
Somebody please, without sounding like a complete effing idiot, give me a reason why you would withhold excellent top line data about a vaccine that is supposed to help brain cancer patients. Just need one reason. Surely someone can give me one reason why you would want to hold amazing trial data for more than four months? One tiny reason. That's all I need. Anyone? Hello?
What an effing joke. All of you people who have been lying about this company for years now should be deeply ashamed.
Why do you apologists always think it's NWBO that's setting a new standard? Every new excuse alleges some unique approach that's never been tried before, because NWBO is such a pioneering trend-setter. But the truth is that there's nothing new under the sun. Never has been and never will be. Because a company is unable to meet status quo requirements for approval, the only way to keep hope alive is to turn them into pioneers! These types of distractions are nothing but excuse-making for failure.
This morning I worked on updating my list of the top 5 reasons why a company with incredibly positive results from a Phase 3 trial would hold on to top line data for more than four months. Here is the updated Top 5:
1.
2.
3.
4.
5.
NWBO is jerking shareholders around again, playing more games because they don't want to release the data from a trial they've known is a failure for at least five years. NWBO is refusing to release the data because they have nothing. If they had good news to share they would have done so by now. You know it. I know it. We all know it. That's the way it is done, that's the way it has always been done, and that's the way it always will be done. To pretend NWBO is some pioneering maverick out to try some new method of releasing good news that involves waiting months and months and months is nothing but poppycock and lies.
Utter and complete nonsense. Why is it that some seem to think NWBO's situation is so unique, so cutting-edge, and so on the verge of setting a new standard? Every new excuse alleges some unique approach that's never been tried before, because NWBO is such a pioneering trend-setter and such a "novelty platform." But the truth is that there's nothing new under the sun. Never has been and never will be. Because a company is unable to meet status quo requirements for approval, the only way to keep hope alive is to turn them into pioneers! These types of distractions are nothing but excuse-making for failure.
This morning I spent a couple of hours developing a list of the top 5 reasons why a company with incredibly positive results from a Phase 3 trial would hold on to top line data for more than four months. Here is my list of reasons:
1.
2.
3.
4.
5.
Yeah, I know, it's not a very deep dive. I might spend little more time on it this afternoon.
There are no unique situations, flipper44, and there is no "novelty of the platform." This whole sham is old news - more than 20 years old. There is no new approach to biotech vaccine approval. The world doesn't work that way. The rules are the rules for a reason. The excuse-making that gets pushed here every day and never ever turns out to be true is really damaging and misleading for gullible people, and there are a lot of gullible people on this message board. NWBO is refusing to release the data because they have nothing. This company is circling the drain, and the people in charge are going to have a lot to answer for civilly, and possibly criminally. I can't speak for anyone else or tell anyone else what to do, but personally, when this is all over I would not want my name, or even my iHub handle, connected with facilitating what is going on here.
You have about 350,000 posts to read going back about 10 years to fully grasp the nature of this company and its future stock potential. Once you finish reading all of those posts you will come to understand that we are right back where we started. Nothing has changed except that the stock showed a brief upward spurt to $2.50 last year based on the company CEO's false promise back in April 2020 that they would lock data on this 14-year-old trial and release top line data in short order. They subsequently pushed that timeline back multiple times, and even put out a statement promising TLD in September 2020. Then, in October 2020, they put out a press release stating they had just locked the data (?). Yes, I know, it's all very confusing.
Since the company blew all the good will and excitement it had generated with the data lock and TLD announcements, the stock has since settled back to the $1.50 range. Most of us recognize this is an unrealistic price range for much longer unless the company finally gets off its ass and does something. They have not communicated with shareholders since that October press release, and the fact that we are now into February 2021 without TLD is not an encouraging sign to say the least.
Some people think they are waiting to publish trial results in a top-tier medical journal. Others of us wonder why, if the data is really as good as some think it is, they would wait to publish a peer-reviewed article when all they really need to do is put out a simple press release announcing whether or not the trial hit its (new) endpoints, and then worry about a journal publication later. Yes, I know, it's all still very confusing.
About those changed endpoints: after 14 years of conducting the trial and right before they decided to lock down the data, some iHub posters here figured out the company has been trying to change the endpoints on the trial. As you can imagine, changing the endpoints on a 14-year-old trial right at the last minute is a highly unusual move and one that wouldn't typically portend good news about the data. But some of the folks here found that the endpoints on the European regulator's web site had been changed (but not on the U.S. FDA clinicaltrials.gov web site). Yes, I know, it just keeps getting more confusing.
Have the changes been approved in Europe but not in the U.S.? Why hasn't clinicaltrials.gov been updated with the new endpoints? These are simple questions that most shareholders would like to have answered, but the fact remains that the company has never said anything to shareholders about changing the endpoints at all. For all we know, it's just another in a long, long list of distractions they have thrown out over the years.
Some of us believe that the company actually found out sometime in 2014-2015 that the trial likely failed to show efficacy on the (then) primary endpoint of PFS. Some people here (or one person anyway) will tell you that a lawsuit filed against the company during this time frame that was subsequently dismissed by a judge proves the company did not learn the trial was missing on PFS efficacy. But others of us believe that the lawsuit was filed just after the company had conducted an Interim Assessment on trial safety, but just before the company conducted an Interim Assessment on endpoint efficacy, so discovery in the case did not include the latter IA's bad news. The greater point is that if you don't think the company had an idea of endpoint efficacy after eight or nine years into the trial, you would have to be either crazy or disingenuous. All of this was concurrent with the FDA halting any new enrollment in the trial for reasons that remain unknown to this day, although the FDA lifted that restriction about 18 months later. And it all coincided with the company crawling into a cave and clearly making the conscious decision that the less communication with shareholders the better, and that the less people know about what is actually going on with the company and its Phase 3 trial the better. It's also around the same time that they completely changed the focus of the trial to concentrate on the alleged "long tail" of survivors, the supposed "gold standard" of GBM drug studies, and hitting "home runs" with that "long tail" data. Why they did not start out using the "long tail" "gold standard" as their primary endpoint, no one has been able to explain.
So here we are, more than three months since they allegedly locked the data and we have not heard an official peep from the company. The people in charge are still the same people who have made millions and millions of dollars by keeping this sham going all these years, and ultimately they have produced absolutely nothing. Now, they are refusing to release the data. So congratulations on your stock purchase because, as you can see, nothing with this company has really changed at all. Your timing is perfect because you haven't missed a thing. It's all still very confusing.
It's remarkable that the stock of a company with no product, zero revenue, many millions in debt, and subterranean credibility is anybody's "stock of the year." Just more confirmation that we now live in Upside Down World.
This line of thinking is so tiresome, and so wrong. People have been expressing this exact sentiment for years and years. Nothing ever changes. They are not "taking the time to give it their best shot." That's not what they are doing. What do they have to do to make it more obvious to you that something is seriously wrong when data was supposedly locked sometime before Oct. 5, and now it's January 30th? Giving it "their best shot" means they are desperately trying to extract something positive from a failed trial - a trial that failed six years ago.
We are rapidly approaching a year since the CEO said they would lock data by the end of May 2020, and we still haven't seen any data. This whole episode has been a bad joke, an exercise in futility, and common shareholders are the victims yet many of them can't even see it. The people in charge of this company have completely blown the release of data from this 14-year-old trial. No one trusts them. No one is going to believe anything they do put out because they've blown every shred of credibility they've ever had. The technology is old. The industry has moved on. NWBO is a relic, and a monument to failure in everything they've done.
There is a slow reckoning happening on this message board. A lot of shareholders who have been in denial for a long time are finally beginning to understand what has really been going on with this company. As the scales fall from their eyes they are beginning to understand that it was all a lie. It is a sickening feeling. I know, because I went through the same thing a couple of years ago. The realization that you have been made a fool is never a good feeling.
What will accompany that experience is the sudden recognition that not only has the company been lying to them, but so have multiple individuals on various media platforms. These are people they counted on to provide information about the state of the company and DCVax-L - people they trusted. But very soon they will come to understand that these individuals have been lying to them, too. That's right. There are many who are personally culpable for spreading lies and misinformation about this company, in some cases for years.
With that understanding the reckoning will shift from mere frustration to outright anger, and I expect we will see a sudden shift away from the normal civility expected on this message board. That's because a lot people are going to be really mad about the lies they've been told over and over and over again. They will be furious about the over-hyped interim data that ultimately turned out to be meaningless. They will be steamed about all the predictions that have been made with such certitude, such as "NICE submission in progress - I have proof!", to dozens of other prognostications about timelines, partnerships and buyouts, employees being hired, Cognate expansions, and so on and so on, that all turned out to be a bunch of nothing. They will be peaved about all the ridiculous parsing of data points that ultimately drew not a single relevant conclusion about PFS, pseudoprogression, crossover or survival. They will be steamed that they allowed themselves to be so willfully coaxed into voting for a share expansion that reduced the value of their investment by two thirds. They will be incensed about all the excuse-making that has gone on here - excuse-making for behavior by a public company that should simply never be accepted or excused away.
Yes, there are many who are culpable here. You know who you are, and I'm sure all of you have your running shoes laced and tied. The reckoning is coming.
Thank you for your posts about this transaction as they have been informative. Since you seem knowledgeable on the topic, I am wondering if you have any thoughts on whether it's possible for the trust to exercise the options and liquidate 3.4 million shares without public disclosure. My limited understanding is that whatever rules applied to the options when they were granted would continue to apply, but it seems to be a somewhat gray area.
As a shareholder, my obvious concern is that an officer and director of the company would try to circumvent public disclosure of a sale of 3.4 million shares by gifting options to a trust, and then the trust executes the sale. Presumably the officer/director in question is executor of the trust, but I'm wondering if there's a clever way around that through power of attorney or some other means and, if so, would we ever know if those shares were sold?
What an effing joke. You expect us to believe the company's IR person is now using private conversations with message board members to relay a multi-month delay? Don't forget at the ASM the CEO said they would lock data by the end of May and we'd have TLD a couple of weeks later. That was eight months ago.
This is such an unbelievable joke. Do you people really think that if they had good news they would be sitting on it? For months and months more? You are insane if you believe that. Just insane. That's not how it works. If you have good news you release it. That's what every company in the history of the world has ever done. You release the Top Line Data and you worry about getting published later.
That's how it works and everybody here knows it. When you have good news you release it! You don't sit on it for months and months! All of this BS about dotting i's and crossing t's is just absurd. You've been saying that FOR YEARS! We also know for a fact that the people in charge of this company are 100 percent confirmed and verified liars. Nothing they have ever told us has turned out to be true or has happened the way they said it would. So why do people here continue to believe them? The only thing you will ever get from these people is more lies.
This is a total scam and I am so sick of it. We have been through these shenanigans so many times now, and it's always the same story. It always comes down to them refusing to release the data. That is the only constant in the last six or seven years - they just won't release the data. The only logical conclusion a neutral observer can draw is that they don't want to release the data. It just couldn't be more obvious. But why? Why are they refusing to release the data?
The cognate expansion doesn't have anything to do with NWBO. Did you read the press release? Apparently a lot of people around here didn't read it. They got all excited last week and posted a bunch of crap on this message board and on Twitter because they thought it would send NWBO's stock through the roof and were dumbfounded when the stock actually dropped. That's because they are like today's teenagers - they don't actually read anything; they just like to jump to conclusions. The cognate press release said nothing about NWBO or anything about the cognate manufacturing expansion being in any way related to the supposed product that NWBO is allegedly, supposedly, presumably one day going to produce but for some unknown reason continues to refuse to release the data on even though they locked the data and began analysis three and half months ago.
Interesting. So is she going to pay back all the self-dealing money she made under the previous arrangement? Oh, that's right, she doesn't even want to pay tax on it. She is a disgrace.
Not sure what you mean by "settle upon administration change"?
I also did not understand this:
I predict you will get another shot at $2.50 when/if they ever release the TLD. What they are going to do is release some lengthy treatise that can be boiled to, "OK, yes the trial failed on all the important stuff, but here are a bunch of great things we learned and here is this tiny little subgroup where we kinda/sorta saw some improvement, so we think we should be approved anyway."
It will take the market about 10 minutes to figure out that the PR is nothing but a smokescreen and that we've all wasted 14 years of our lives, so you had best be ready to pull the trigger. Don't get too greedy. Take your profit and go home thankful that you were able to squeeze something out of this execrable disgrace.
All those "old tricks" people are using to make NWBO look bad. If it weren't for those old tricks, NWBO would look just great.
I would say what you are doing is recycling old tropes that don't have any basis in reality. The fact this company looks bad is 100 percent its own doing. Zero communication with shareholders except for lies. Three and half months late and still going on filing third quarter 10Q. It's really ridiculous to suggest that the problem here isn't self-made. You yourself have written the same many times in the past. Now there seems to be a reek of panic and desperation in the air.
Doc, you are correct that I misinterpreted Thermo's holdings. However, he has not "made" anything until he sells, and I know you know that. Since he claims to have not sold a share, then my point stills stands. He may be a strong believer in the science of DCVax, as I believe most of us are, but he is also putting his trust for the future of his rather large investment in the management of this company. Yes, the value of his investment has climbed on paper, but until he sells he hasn't made a dime, and that means he's still trusting these people. He hasn't cashed in his chips; he's still rolling the dice.
I sold some at $1.72 a couple of weeks ago, but I'm also still holding a sizeable chunk because I think it's going to pop at least one more time before they disappoint us. It may even pop into the $2.50-$3.00 range if we are lucky. Anyone who is still holding after that is going to be in for a rude surprise because, as I have said a thousand times, the people running this company have shown themselves to be liars and the only thing they know how to do is disappoint. That's the pattern they have established over the last seven, eight, nine years or more. Constant disappointment. That's who they are. That's what they do. It's not going to change.
That's the point I was making. There is a major disconnect with many of the people who post here who cannot see that there are two distinct elements to drug approval. The product may be great, but you have to have competent people to get it through the approval process. The approval process for DCVax has been missing competent people since the beginning (Dr. Liau is competent, but she is not NWBO and she is not involved in the approval process). If you can't prove the drug is great, then nothing else matters.
There are people here arguing I should be grateful for making some profit at $1.72, but that's not why I invested in this company seven years ago. It took me seven years of averaging down before I could get to a point where I could make a profit at $1.72. The promise here and the hype here has always been about something far greater than $1.72, but after all this time it has become quite clear that those higher expectations will never be realized because of the people in charge of proving DCVax works. All they do is disappoint.
Are you referring to Thermo? I'm not familiar with what he has written about management. He comes across as a straight shooter, but the psychology of his story is peculiar. I am just not personally familiar with any investors of his stature willing to risk $100 million on what essentially amounts to a Vegas craps shoot. That doesn't mean I don't believe him. I do. He's just a unique specimen.
Every now and then you will read about some whale dropping $1 million or $2 million at the craps or roulette tables - but $100 million? I don't know. That seems like a lot of money for anyone, and the idea of betting it all on the Keystone Cops seems a little odd to me. There is a dichotomy here that seems to elude a lot of folks, and that is the dissonance between the science and the management. DCVax can be the miracle we all want it to be, but if the people charged with proving its effectiveness aren't up to the task, then, in the end, it doesn't really matter if DCVax works. I am convinced that Dr. Linda Liau became aware of this problem some time ago and now realizes that she wasted 14 years on these people and that if she wants her life's work to be validated she's going to have to do it herself.
Everyone who puts their trust in NWBO eventually comes to this realization. For some, it just takes longer. Not to make too many assumptions, but if you are asking me to guess I would say that, like many before him, Thermo probably did an exhaustive amount of research on DCVax before committing his $100 million. And now, also like many before him, he's probably wishing he had given as much time to researching the people charged with proving its efficacy.
Yes, your post is 100 percent spot on. It's all about the character of the people you have chosen to trust, and these people have revealed their character over and over again, and it's not a pretty sight. They are liars. They lie to shareholders constantly and then just pretend like whatever they said before never happened. They test the SEC and creditors and try to get away with whatever they can get away with. I don't like these people at all and I wish I had never given them my money. It just amazes me that there are people here who still trust them and think they are going to win Nobel Prizes and such. It's just beyond laughable. It's actually just sad. It doesn't have anything to do with DCVax. It has everything to do with the people running this company being a disgrace. These people have shown us who they are.
Yes, you are correct. Flaskworks is literally two people at Northeastern University who designed a device. No one knows if the device works, and there is no manufacturing platform. NWBO bought the device for a couple of million dollars and a few shares of stock. A full endoscopy would take about 10 minutes.
There is a lot more to this delay. But the good news is we know the staff at NWBO worked all through the Christmas holidays and, presumably, on New Year's Eve, too. Rumor has it they plan to work hard all through this weekend and have pledged not to watch any NFL playoff games. Next week the plan is to update shareholders on how hard they are working.
What I have been trying to tell everyone on this board for a long time but for some reason no one wants to believe is that NWBO lies with impunity - about everything - and they have no qualms about telling lies to spur a quick bump in the share price.
The Sawston PR was another example of a pump scheme that temporarily jacked up the share price so their financiers could make a quick buck. These PRs, 8Ks, and other public statements, such as, "You definitely should consider coming to the ASM. It's going to be interesting!", always seem to come right on the heels of financings that allow them to keep paying themselves. The only way NWBO can get anyone to agree to lend them money (would you lend them money?) is to almost guarantee a quick payback with a tidy profit. So these financiers lend them typically five to ten million dollars per clip and get warrants in return. The company then makes a positive forward-looking public statement that results in a sudden rise in the share price, albeit temporary and even though the statement itself is a bald-faced lie - such as "Sawston due for completion in October." The financiers then cash out for a nice profit, and, oddly, you never hear another word from the company about that Sawston build out.
It is a nice game, and I am convinced they've been playing it for a long time. The people running this company are compulsive liars from the CEO down to the IR guy. It's time for this charade to end. Aren't people sick and tired of being lied to with everything this company says, just like the Sawston statement and all the promises of data lock and TLD? It's just insane that people still believe there's something good going on here. Yesterday I asked a simple question that got no response: Can anyone name a single instance over the last five years where this company has said something will happen, and that thing actually happened exactly as promised? I don't think it's ever happened. Like I said, they are just compulsive liars.